GlassScriptPhysician profile
Priscila Martinez
NPI 1104248830
$2,196.70
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,871 · 2022: $243 · 2023: $14.07 · 2024: $69.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,218.96 | 2021 | |
| Novo Nordisk INC | $288.06 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.68 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $86.33 | 2021-2024 | Nuzyra |
| Abbvie INC. | $83.44 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $59.02 | 2021-2024 | Farxiga |
| Sanofi-Aventis U.S. LLC | $48.25 | 2021-2022 | |
| Pfizer INC. | $43.61 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.22 | 2021-2022 | |
| Eisai INC. | $30.69 | 2021 | |
| Idorsia Pharmaceuticals US INC | $17.55 | 2024 | Quviviq |
| Biogen, INC. | $15.53 | 2021 | |
| Astellas Pharma US INC | $14.64 | 2021 | |
| Lilly USA, LLC | $14.52 | 2021 | |
| Sunovion Pharmaceuticals INC. | $14.09 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $14.02 | 2022 | |
| Amarin Pharma, INC. | $13.42 | 2022 | |
| Merck Sharp & Dohme LLC | $13.04 | 2021 | |
| Glaxosmithkline, LLC. | $12.76 | 2021 | |
| Currax Pharmaceuticals LLC | $12.30 | 2021 | |
| Nabriva Therapeutics, Plc | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscila Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.